Shares of United Therapeutics Corporation (UTHR) are climbing about 9 percent on Wednesday morning trading following the announcement of its fourth-quarter financial results, which revealed earnings of $364.3 million, or $7.70 per share, up from last year's $301.3 million, or $6.19 per share.
The company's stock is currently trading at $516.11, up 9.02 percent or $42.68, over the previous close of $473.43 on the Nasdaq. It has traded between $266.98 and $530.00 in the past one year.
The company's revenue for the period rose 7.4 percent, to $790.2 million from $735.9 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.